# Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions

> **NCT04906785** · PHASE1 · UNKNOWN · sponsor: **Chong Kun Dang Pharmaceutical** · enrollment: 52 (estimated)

## Conditions studied

- Cardiovascular Diseases

## Interventions

- **DRUG:** CKD-385
- **DRUG:** D744

## Key facts

- **NCT ID:** NCT04906785
- **Lead sponsor:** Chong Kun Dang Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-04
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-06
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2021-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04906785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04906785, "Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04906785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*